Compare Abeona Therapeutics Inc (ABEO) vs Western Digital Corp (WDC) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs Western Digital Corp — how do they compare? Abeona Therapeutics Inc trades at $6.73 (market cap $373.32M), while Western Digital Corp trades at $534.68 (market cap $183.41B). The key difference: Western Digital Corp is far larger — about 491.3× Abeona Therapeutics Inc's market cap, and Western Digital Corp pays a 0.11% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | WDC | |
|---|---|---|
Market Cap | $373.32M | $183.41B |
Sector | Health | Technology |
52-Week High | $7.23 | $746.23 |
52-Week Low | $4.17 | $64.02 |
Enterprise Value | $228.22M | $181.75B |
Dividend Yield | — | 0.11% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
Western Digital (WDC) trades at $532.1, down 1.28% amid a sector-wide memory stock sell-off. The stock shows strong fundamentals with three consecutive quarterly earnings beats and a net income margin of 55.07% in 2025. Analyst consensus is strongly bullish with a $607.46 price target, though technical indicators signal near-term bearish pressure with support at $523.
Outlook remains positive driven by AI and data center demand, but volatility from memory pricing cycles and competitive pressures pose risks. Upside depends on continued execution and sector momentum, with the current dip potentially offering entry for growth-oriented investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Western Digital Corp
Western Digital is a vertically integrated supplier of data storage solutions, spanning both hard disk drives and solid-state drives. In the HDD market it forms a practical duopoly with Seagate, and it is the largest global producer of NAND flash chips for SSDs in a joint venture with competitor Kioxia.
Read more on WDC →
